Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Venrock Healthcare Capital Partners III, L.P.'s stake in Dianthus Therapeutics, Inc. fell to 3.10% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Venrock Healthcare Capital Partners III, L.P.'s stake in Dianthus Therapeutics, Inc. fell to 3.10%, 1,000,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 3.10%
- Shares
- 1,000,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 3.10% | 1,000,000 |
| VHCP Co-Investment Holdings III, LLC | 3.10% | 1,000,000 |
| Venrock Healthcare Capital Partners EG, L.P. | 3.10% | 1,000,000 |
| VHCP Management III, LLC | 3.10% | 1,000,000 |
| VHCP Management EG, LLC | 3.10% | 1,000,000 |
| Nimish Shah | 3.10% | 1,000,000 |
| Bong Y. Koh | 3.10% | 1,000,000 |
Source
Related
- Dianthus Therapeutics, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Dianthus Therapeutics, Inc. shareholders
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026